Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Refractory Autoimmune Diseases”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Looking for participantsNCT07547930
What this trial is testing

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease, TEDGraves OphthalmopathyGraves Orbitopathy
The First Affiliated Hospital of Xiamen University 8
Very early researchLooking for participantsNCT07526350
What this trial is testing

MTS109 in Patients With Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis (SSc)+2 more
Shanghai Changzheng Hospital 15
Not applicableLooking for participantsNCT07681388
What this trial is testing

CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Jinbo Chen 3
Very early researchLooking for participantsNCT07122076
What this trial is testing

GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Grit Biotechnology 10
Testing effectiveness (Phase 2)WithdrawnNCT00296205
What this trial is testing

Phase II High-Dose Cyclophosphamide for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Stony Brook University 25
Early research (Phase 1)Looking for participantsNCT06822881
What this trial is testing

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)
Beijing GoBroad Hospital 27
Very early researchLooking for participantsNCT06010472
What this trial is testing

An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Changhai Hospital 36
Testing effectiveness (Phase 2)Study completedNCT05460832
What this trial is testing

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Who this might be right for
Rheumatoid Arthritis
Modern Biosciences Ltd 248
Large-scale testing (Phase 3)Active Not RecruitingNCT04539964
What this trial is testing

Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SetPoint Medical Corporation 243
Testing effectiveness (Phase 2)Looking for participantsNCT07513181
What this trial is testing

Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
Athos Therapeutics Inc 120
Early research (Phase 1)Ended earlyNCT06087406
What this trial is testing

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, RheumatoidArthritis
IGM Biosciences, Inc. 33
Very early researchLooking for participantsNCT07333118
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of GT801 Injection in the Treatment of Moderate-to-Severe Refractory Autoimmune Diseases

Who this might be right for
Moderate to Severe Refractory Autoimmune Disease
Grit Biotechnology 22
Early research (Phase 1)Looking for participantsNCT07031713
What this trial is testing

Safety, Efficacy and Cellular Metabolic Dynamics of ct1192 in Patients With Moderate to Severe Refractory SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Early research (Phase 1)Looking for participantsNCT06349343
What this trial is testing

CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 20
Very early researchNot Yet RecruitingNCT06982547
What this trial is testing

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Very early researchLooking for participantsNCT07132112
What this trial is testing

GT719 Injection for Moderate to Severe Refractory Autoimmune Disease

Who this might be right for
Auto Immune Disease
Grit Biotechnology 30
Not applicableLooking for participantsNCT07017686
What this trial is testing

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
The Bionics Institute of Australia 5
Very early researchLooking for participantsNCT07339332
What this trial is testing

A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 12
Testing effectiveness (Phase 2)WithdrawnNCT01236456
What this trial is testing

High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy

Who this might be right for
Chronic Inflammatory Demyelinating Polyneuropathy
Stony Brook University
Next Page